FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006353464> ?p ?o ?g. }

• W2006353464 endingPage "1790" @default.
• W2006353464 startingPage "1783" @default.
• W2006353464 abstract "Accumulating evidence suggests that C-reactive protein (CRP), in addition to predicting vascular disease, may actively facilitate lesion formation by inciting endothelial cell activation. Given the central importance of angiotensin type 1 receptor (AT1-R) in the pathogenesis of atherosclerosis, we examined the effects of CRP on AT1-R expression and kinetics in vascular smooth muscle (VSM) cells. In addition, the effects of CRP on VSM migration, proliferation, and reactive oxygen species (ROS) production were evaluated in the presence and absence of the angiotensin receptor blocker, losartan. Lastly, the effects of CRP (and losartan) on neointimal formation were examined in vivo in a rat carotid angioplasty model.The effects of human recombinant CRP (0 to 100 microg/mL) on AT1-R transcript, mRNA stability, and protein expression were studied in cultured human VSM cells. AT1-R binding was assessed with 125I-labeled angiotensin II (Ang II). VSM migration was assessed with wound cell migration assays, whereas VSM proliferation was determined with [3H]-incorporation and cell number. The effects of CRP (and losartan) on Ang II-induced ROS production were evaluated by 2',7'-dichlorofluorescein fluorescence. Lastly, the effects of CRP (and losartan) on neointimal formation, VSM cell migration, proliferation, and matrix formation were studied in vivo in a rat carotid artery balloon injury model. CRP markedly upregulated AT1-R mRNA and protein expression and increased AT1-R number on VSM cells. CRP promoted VSM migration and proliferation in vitro and increased ROS production. Furthermore, CRP potentiated the effects of Ang II on these processes. In the rat carotid artery angioplasty model, exposure to CRP resulted in an increase in cell migration and proliferation, collagen and elastin content, and AT1-R expression, as well as an increase in neointimal formation; these effects were attenuated by losartan.CRP, at concentrations known to predict cardiovascular events, upregulates AT1-R-mediated atherosclerotic events in vascular smooth muscle in vitro and in vivo. These data lend credence to the notion that CRP functions as a proatherosclerotic factor as well as a powerful risk marker." @default.
• W2006353464 created "2016-06-24" @default.
• W2006353464 creator A5005862142 @default.
• W2006353464 creator A5047937368 @default.
• W2006353464 creator A5049131213 @default.
• W2006353464 creator A5056407096 @default.
• W2006353464 creator A5056544915 @default.
• W2006353464 creator A5059146591 @default.
• W2006353464 creator A5077394728 @default.
• W2006353464 creator A5080334509 @default.
• W2006353464 creator A5086698591 @default.
• W2006353464 date "2003-04-08" @default.
• W2006353464 modified "2023-09-29" @default.
• W2006353464 title "C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle" @default.
• W2006353464 cites W180946569 @default.
• W2006353464 cites W1974509672 @default.
• W2006353464 cites W1974968671 @default.
• W2006353464 cites W1979978633 @default.
• W2006353464 cites W2005027963 @default.
• W2006353464 cites W2018135697 @default.
• W2006353464 cites W2030518401 @default.
• W2006353464 cites W2032485049 @default.
• W2006353464 cites W2043118966 @default.
• W2006353464 cites W2045065016 @default.
• W2006353464 cites W2053634523 @default.
• W2006353464 cites W2058610272 @default.
• W2006353464 cites W2059279349 @default.
• W2006353464 cites W2062378217 @default.
• W2006353464 cites W2066963386 @default.
• W2006353464 cites W2070396041 @default.
• W2006353464 cites W2074940919 @default.
• W2006353464 cites W2079404203 @default.
• W2006353464 cites W2085058703 @default.
• W2006353464 cites W2088436731 @default.
• W2006353464 cites W2095494894 @default.
• W2006353464 cites W2097796010 @default.
• W2006353464 cites W2106775861 @default.
• W2006353464 cites W2123437217 @default.
• W2006353464 cites W2138135866 @default.
• W2006353464 cites W2147657686 @default.
• W2006353464 cites W2148322270 @default.
• W2006353464 cites W2161465441 @default.
• W2006353464 doi "https://doi.org/10.1161/01.cir.0000061916.95736.e5" @default.
• W2006353464 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12665485" @default.
• W2006353464 hasPublicationYear "2003" @default.
• W2006353464 type Work @default.
• W2006353464 sameAs 2006353464 @default.
• W2006353464 citedByCount "501" @default.
• W2006353464 countsByYear W20063534642012 @default.
• W2006353464 countsByYear W20063534642013 @default.
• W2006353464 countsByYear W20063534642014 @default.
• W2006353464 countsByYear W20063534642015 @default.
• W2006353464 countsByYear W20063534642016 @default.
• W2006353464 countsByYear W20063534642017 @default.
• W2006353464 countsByYear W20063534642018 @default.
• W2006353464 countsByYear W20063534642019 @default.
• W2006353464 countsByYear W20063534642020 @default.
• W2006353464 countsByYear W20063534642021 @default.
• W2006353464 countsByYear W20063534642022 @default.
• W2006353464 countsByYear W20063534642023 @default.
• W2006353464 crossrefType "journal-article" @default.
• W2006353464 hasAuthorship W2006353464A5005862142 @default.
• W2006353464 hasAuthorship W2006353464A5047937368 @default.
• W2006353464 hasAuthorship W2006353464A5049131213 @default.
• W2006353464 hasAuthorship W2006353464A5056407096 @default.
• W2006353464 hasAuthorship W2006353464A5056544915 @default.
• W2006353464 hasAuthorship W2006353464A5059146591 @default.
• W2006353464 hasAuthorship W2006353464A5077394728 @default.
• W2006353464 hasAuthorship W2006353464A5080334509 @default.
• W2006353464 hasAuthorship W2006353464A5086698591 @default.
• W2006353464 hasBestOaLocation W20063534641 @default.
• W2006353464 hasConcept C104849204 @default.
• W2006353464 hasConcept C123915805 @default.
• W2006353464 hasConcept C126322002 @default.
• W2006353464 hasConcept C134018914 @default.
• W2006353464 hasConcept C170493617 @default.
• W2006353464 hasConcept C2777387769 @default.
• W2006353464 hasConcept C2779395532 @default.
• W2006353464 hasConcept C2780288358 @default.
• W2006353464 hasConcept C2908929049 @default.
• W2006353464 hasConcept C2992686903 @default.
• W2006353464 hasConcept C48349386 @default.
• W2006353464 hasConcept C71924100 @default.
• W2006353464 hasConcept C84393581 @default.
• W2006353464 hasConcept C86803240 @default.
• W2006353464 hasConcept C95444343 @default.
• W2006353464 hasConceptScore W2006353464C104849204 @default.
• W2006353464 hasConceptScore W2006353464C123915805 @default.
• W2006353464 hasConceptScore W2006353464C126322002 @default.
• W2006353464 hasConceptScore W2006353464C134018914 @default.
• W2006353464 hasConceptScore W2006353464C170493617 @default.
• W2006353464 hasConceptScore W2006353464C2777387769 @default.
• W2006353464 hasConceptScore W2006353464C2779395532 @default.
• W2006353464 hasConceptScore W2006353464C2780288358 @default.
• W2006353464 hasConceptScore W2006353464C2908929049 @default.
• W2006353464 hasConceptScore W2006353464C2992686903 @default.
• W2006353464 hasConceptScore W2006353464C48349386 @default.
• W2006353464 hasConceptScore W2006353464C71924100 @default.

• next